Heme oxygenase-1 accelerates tumor angiogenesis of human pancreatic cancer.

Abstract:

:Angiogenesis is necessary for the continued growth of solid tumors, invasion and metastasis. Several studies clearly showed that heme oxygenase-1 (HO-1) plays an important role in angiogenesis. In this study, we used the vital microscope system, transparent skinfold model, lung colonization model and transduced pancreatic cancer cell line (Panc-1)/human heme oxygenase-1 (hHO-1) cells, to precisely analyze, for the first time, the effect of hHO-1 gene on tumor growth, angiogenesis and metastasis. Our results revealed that HO-1 stimulates angiogenesis of pancreatic carcinoma in severe combined immune deficient mice. Overexpression of human hHO-1 after its retroviral transfer into Panc-1 cells did not interfere with tumor growth in vitro. While in vivo the development of tumors was accelerated upon transfection with hHO-1. On the other hand, inhibition of heme oxygenase (HO) activity by stannous mesoporphyrin was able transiently to delay tumor growth in a dose dependent manner. Tumor angiogenesis was markedly increased in Panc-1/hHO-1 compared to mock transfected and wild type. Lectin staining and Ki-67 proliferation index confirmed these results. In addition hHO-1 stimulated in vitro tumor angiogenesis and increased endothelial cell survival. In a lung colonization model, overexpression of hHO-1 increased the occurrence of metastasis, while inhibition of HO activity by stannous mesoporphyrin completely inhibited the occurrence of metastasis. In conclusion, overexpression of HO-1 genes potentiates pancreatic cancer aggressiveness, by increasing tumor growth, angiogenesis and metastasis and that the inhibition of the HO system may be of useful benefit for the future treatment of the disease.

journal_name

Angiogenesis

journal_title

Angiogenesis

authors

Sunamura M,Duda DG,Ghattas MH,Lozonschi L,Motoi F,Yamauchi J,Matsuno S,Shibahara S,Abraham NG

doi

10.1023/a:1025803600840

subject

Has Abstract

pub_date

2003-01-01 00:00:00

pages

15-24

issue

1

eissn

0969-6970

issn

1573-7209

pii

5143525

journal_volume

6

pub_type

杂志文章
  • Transcriptional regulation of the vascular endothelial glycome by angiogenic and inflammatory signalling.

    abstract::Vascular endothelial cells undergo many molecular changes during pathological processes such as inflammation and tumour development. Tumours such as malignant lymphomas affecting bone marrow are dependent on interactions with endothelial cells for (1) site-specific homing and (2) tumour-induced angiogenesis. Modificat...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1007/s10456-010-9162-4

    authors: Willhauck-Fleckenstein M,Moehler TM,Merling A,Pusunc S,Goldschmidt H,Schwartz-Albiez R

    更新日期:2010-03-01 00:00:00

  • TM4SF1: a new vascular therapeutic target in cancer.

    abstract::Transmembrane-4 L-six family member-1 (TM4SF1) is a small plasma membrane glycoprotein that regulates cell motility and proliferation. TM4SF1 is an attractive cancer target because of its high expression in both tumor cells and on the vascular endothelial cells lining tumor blood vessels. We generated mouse monoclonal...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1007/s10456-014-9437-2

    authors: Lin CI,Merley A,Sciuto TE,Li D,Dvorak AM,Melero-Martin JM,Dvorak HF,Jaminet SC

    更新日期:2014-10-01 00:00:00

  • Contrasting effects of sunitinib within in vivo models of metastasis.

    abstract::Sunitinib is a potent and clinically approved tyrosine kinase inhibitor that can suppress tumour growth by inhibiting angiogenesis. However, conflicting data exist regarding the effects of this drug on the growth of metastases in preclinical models. Here we use 4T1 and RENCA tumour cells, which both form lung metastas...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1007/s10456-012-9291-z

    authors: Welti JC,Powles T,Foo S,Gourlaouen M,Preece N,Foster J,Frentzas S,Bird D,Sharpe K,van Weverwijk A,Robertson D,Soffe J,Erler JT,Pili R,Springer CJ,Mather SJ,Reynolds AR

    更新日期:2012-12-01 00:00:00

  • Protein kinase D2 and heat shock protein 90 beta are required for BCL6-associated zinc finger protein mRNA stabilization induced by vascular endothelial growth factor-A.

    abstract::Vascular endothelial growth factor (VEGF) is a major angiogenic factor that activates pro-angiogenic molecules to generate new vessels. Recently, we identified a VEGF-A-induced pro-angiogenic gene, BCL-6 associated zinc finger protein (BAZF), in endothelial cells. BAZF interacts with CBF1, a transcriptional regulator ...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1007/s10456-013-9345-x

    authors: Miwa D,Sakaue T,Inoue H,Takemori N,Kurokawa M,Fukuda S,Omi K,Goishi K,Higashiyama S

    更新日期:2013-07-01 00:00:00

  • Inflammation-induced lymphangiogenesis and lymphatic dysfunction.

    abstract::The lymphatic system is intimately linked to tissue fluid homeostasis and immune cell trafficking. These functions are paramount in the establishment and development of an inflammatory response. In the past decade, an increasing number of reports has revealed that marked changes, such as lymphangiogenesis and lymphati...

    journal_title:Angiogenesis

    pub_type: 杂志文章,评审

    doi:10.1007/s10456-014-9416-7

    authors: Liao S,von der Weid PY

    更新日期:2014-04-01 00:00:00

  • Suppression of vascular network formation by chronic hypoxia and prolyl-hydroxylase 2 (phd2) deficiency during vertebrate development.

    abstract::In the adult, new vessels and red blood cells form in response to hypoxia. Here, the oxygen-sensing system (PHD-HIF) has recently been put into focus, since the prolyl-hydroxylase domain proteins (PHD) and hypoxia-inducible factors (HIF) are considered as potential therapeutic targets to treat ischemia, cancers or age...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1007/s10456-015-9492-3

    authors: Metikala S,Neuhaus H,Hollemann T

    更新日期:2016-04-01 00:00:00

  • CMTM4 regulates angiogenesis by promoting cell surface recycling of VE-cadherin to endothelial adherens junctions.

    abstract::Vascular endothelial (VE) cadherin is a key component of endothelial adherens junctions (AJs) and plays an important role in maintaining vascular integrity. Endocytosis of VE-cadherin regulates junctional strength and a decrease of surface VE-cadherin reduces vascular stability. However, disruption of AJs is also a re...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1007/s10456-018-9638-1

    authors: Chrifi I,Louzao-Martinez L,Brandt MM,van Dijk CGM,Bürgisser PE,Zhu C,Kros JM,Verhaar MC,Duncker DJ,Cheng C

    更新日期:2019-02-01 00:00:00

  • Endothelial cells expressing low levels of CD143 (ACE) exhibit enhanced sprouting and potency in relieving tissue ischemia.

    abstract::The sprouting of endothelial cells from pre-existing blood vessels represents a critical event in the angiogenesis cascade. However, only a fraction of cultured or transplanted endothelial cells form new vessels. Moreover, it is unclear whether this results from a stochastic process or instead relates to certain endot...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1007/s10456-014-9414-9

    authors: Silva EA,Eseonu C,Mooney DJ

    更新日期:2014-07-01 00:00:00

  • VEGFA gene locus analysis across 80 human tumour types reveals gene amplification in several neoplastic entities.

    abstract:BACKGROUND:Angiogenesis plays a pivotal role in neoplastic growth and metastasis formation. Vascular endothelial growth factor A (VEGFA) is a major player in physiological and tumour-induced angiogenesis and numerous human tumours have been show to overexpress VEGFA. Moreover increased VEGFA gene expression has been fo...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1007/s10456-013-9396-z

    authors: Andreozzi M,Quagliata L,Gsponer JR,Ruiz C,Vuaroqueaux V,Eppenberger-Castori S,Tornillo L,Terracciano LM

    更新日期:2014-07-01 00:00:00

  • Adgrf5 contributes to patterning of the endothelial deep layer in retina.

    abstract::Neovascularization of the inner retinal space is a major cause of vision loss. In retinal angiomatous proliferation (RAP) syndrome, newly formed vessels originate from the retinal plexus and invade the inner retinal space. However, the molecular pathways preventing subretinal vascularization remain largely unknown. In...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1007/s10456-019-09674-0

    authors: Niaudet C,Petkova M,Jung B,Lu S,Laviña B,Offermanns S,Brakebusch C,Betsholtz C

    更新日期:2019-11-01 00:00:00

  • The impact of EPLINα (Epithelial protein lost in neoplasm) on endothelial cells, angiogenesis and tumorigenesis.

    abstract:BACKGROUND:EPLIN (epithelial protein lost in neoplasm) is a cytoskeletal associated protein involved in the regulation of actin dynamics and subsequently in cell motility. EPLIN expression is frequently reduced in a variety of cancer cells and tissues and this loss may account for increased invasive traits in cancer ce...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1007/s10456-010-9188-7

    authors: Sanders AJ,Ye L,Mason MD,Jiang WG

    更新日期:2010-12-01 00:00:00

  • GSK-3β: a signaling pathway node modulating neural stem cell and endothelial cell interactions.

    abstract::The neurogenic areas of the brain are highly organized structures in which there is dynamic reciprocal modulation of neural stem cells (NSC) and microvascular endothelial cells (BEC) resulting in control of neural stem cell and vascular proliferation, survival and differentiation throughout the life of the individual....

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1007/s10456-011-9201-9

    authors: Li Q,Michaud M,Canosa S,Kuo A,Madri JA

    更新日期:2011-05-01 00:00:00

  • Plants and their active compounds: natural molecules to target angiogenesis.

    abstract::Angiogenesis, or new blood vessel formation, is an important process in the pathogenesis of several diseases and thus has been targeted for the prevention and treatment for many disorders. However, the anti-angiogenic agents that are currently in use are mainly synthetic compounds and humanized monoclonal antibodies, ...

    journal_title:Angiogenesis

    pub_type: 杂志文章,评审

    doi:10.1007/s10456-016-9512-y

    authors: Lu K,Bhat M,Basu S

    更新日期:2016-07-01 00:00:00

  • The role of endoglin in post-ischemic revascularization.

    abstract::Following arterial occlusion, blood vessels respond by forming a new network of functional capillaries (angiogenesis), by reorganizing preexisting capillaries through the recruitment of smooth muscle cells to generate new arteries (arteriogenesis) and by growing and remodeling preexisting collateral arterioles into ph...

    journal_title:Angiogenesis

    pub_type: 杂志文章,评审

    doi:10.1007/s10456-016-9535-4

    authors: Núñez-Gómez E,Pericacho M,Ollauri-Ibáñez C,Bernabéu C,López-Novoa JM

    更新日期:2017-02-01 00:00:00

  • Recombinant human prothrombin kringles have potent anti-angiogenic activities and inhibit Lewis lung carcinoma tumor growth and metastases.

    abstract::Prothrombin, a protein involved in blood coagulation, is a plasma glycoprotein composed of the Gla domain, two adjacent kringle domains, and a serine protease domain. Kringles are triple-disulfide-loop folding domains, which are found in several other blood proteins. In this study, we showed that recombinant human pro...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1023/a:1023835102832

    authors: Kim TH,Kim E,Yoon D,Kim J,Rhim TY,Kim SS

    更新日期:2002-01-01 00:00:00

  • Characterization of a drug-targetable allosteric site regulating vascular endothelial growth factor signaling.

    abstract::Vascular endothelial growth factors (VEGFs) regulate blood and lymph vessel development upon activation of three receptor tyrosine kinases (VEGFRs). The extracellular domain of VEGFRs consists of seven Ig-homology domains, of which D2-3 form the ligand-binding site, while the membrane proximal domains D4-7 are involve...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1007/s10456-018-9606-9

    authors: Thieltges KM,Avramovic D,Piscitelli CL,Markovic-Mueller S,Binz HK,Ballmer-Hofer K

    更新日期:2018-08-01 00:00:00

  • Inhibition of B16 melanoma growth in vivo by retroviral vector-mediated human ribonuclease inhibitor.

    abstract::Human ribonuclease inhibitor (hRI) can inhibit angiogenesis by reversibly binding angiogenin, a member of the RNaseA superfamily, and by suppressing the expression of basic fibroblast growth factor (bFGF). Angiogenesis is necessary for the growth and metastasis of tumors. To study the links between hRI, angiogenesis, ...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1007/s10456-005-5714-4

    authors: Wang T,Yang M,Chen J,Watkins T,Xiuyun C

    更新日期:2005-01-01 00:00:00

  • Hanging-drop multicellular spheroids as a model of tumour angiogenesis.

    abstract::The establishment of a vascular network within tumours is a key step in the progression towards an aggressive, metastatic state, with poor prognosis. We have developed a novel in vitro model to specifically capture the interaction between endothelial cells and solid tumours. Micro-vascularised in vitro tumour construc...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1007/s10456-004-8911-7

    authors: Timmins NE,Dietmair S,Nielsen LK

    更新日期:2004-01-01 00:00:00

  • Angiogenesis in arthritis: role in disease pathogenesis and as a potential therapeutic target.

    abstract::Rheumatoid arthritis (RA) is a chronic destructive musculo-skeletal disorder, associated with thickening of the synovial membrane lining the joints, inflammation and hyperproliferation of synovial cells, as well as a pro-inflammatory cytokine cascade, leukocyte infiltration, and tissue damage and bone resorption. An e...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1023/a:1009229508096

    authors: Paleolog EM,Miotla JM

    更新日期:1998-01-01 00:00:00

  • Pazopanib may reduce bleeding in hereditary hemorrhagic telangiectasia.

    abstract::Pazopanib (Votrient) is an orally administered tyrosine kinase inhibitor that blocks VEGF receptors potentially serving as anti-angiogenic treatment for hereditary hemorrhagic telangiectasia (HHT). We report a prospective, multi-center, open-label, dose-escalating study [50 mg, 100 mg, 200 mg, and 400 mg], designed as...

    journal_title:Angiogenesis

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1007/s10456-018-9646-1

    authors: Faughnan ME,Gossage JR,Chakinala MM,Oh SP,Kasthuri R,Hughes CCW,McWilliams JP,Parambil JG,Vozoris N,Donaldson J,Paul G,Berry P,Sprecher DL

    更新日期:2019-02-01 00:00:00

  • TM4SF1: a tetraspanin-like protein necessary for nanopodia formation and endothelial cell migration.

    abstract::Transmembrane-4-L-six-family-1 (TM4SF1) is a tetraspanin-like membrane protein that is highly and selectively expressed by cultured endothelial cells (EC) and, in vivo, by EC lining angiogenic tumor blood vessels. TM4SF1 is necessary for the formation of unusually long (up to a 50 μm), thin (~100-300 nm wide), F-actin...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1007/s10456-011-9218-0

    authors: Zukauskas A,Merley A,Li D,Ang LH,Sciuto TE,Salman S,Dvorak AM,Dvorak HF,Jaminet SC

    更新日期:2011-09-01 00:00:00

  • Neutrophil granulocyte derived MMP-9 is a VEGF independent functional component of the angiogenic switch in pancreatic ductal adenocarcinoma.

    abstract:BACKGROUND:Vascular endothelial growth factor (VEGF) that is secreted by tumor cells plays a key role in angiogenesis. Matrix metalloproteinase 9 (MMP-9) is produced by inflammatory cells, such as stromal granulocytes (PMN), remodels the extracellular matrix and is known to promote angiogenesis indirectly by interactin...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1007/s10456-011-9207-3

    authors: Bausch D,Pausch T,Krauss T,Hopt UT,Fernandez-del-Castillo C,Warshaw AL,Thayer SP,Keck T

    更新日期:2011-09-01 00:00:00

  • New anti-angiogenesis agents: review of the clinical experience with carboxyamido-triazole (CAI), thalidomide, TNP-470 and interleukin-12.

    abstract::Angiogenesis was postulated to be a critical prognostic factor and therapeutic focus for malignancy more than two decades ago. Recent studies indicate quantitative assessments of microvessel count to be an independent prognostic variable for disease-free and overall survival in a wide variety of tumors, and that angio...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1023/A:1018301031580

    authors: Masiero L,Figg WD,Kohn EC

    更新日期:1997-01-01 00:00:00

  • Targeting endothelial thioredoxin-interacting protein (TXNIP) protects from metabolic disorder-related impairment of vascular function and post-ischemic revascularisation.

    abstract:INTRODUCTION:Although thioredoxin-interacting protein (TXNIP) is involved in a variety of biological functions, the contribution of endothelial TXNIP has not been well-defined in regards to endothelial and vascular function or in post-ischemic revascularisation. We postulated that inhibition of endothelial TXNIP with s...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1007/s10456-019-09704-x

    authors: Domingues A,Boisson-Vidal C,Marquet de Rouge P,Dizier B,Sadoine J,Mignon V,Vessières E,Henrion D,Escriou V,Bigey P,Chaussain C,Smadja DM,Nivet-Antoine V

    更新日期:2020-05-01 00:00:00

  • Shear stress-induced transcriptional regulation via hybrid promoters as a potential tool for promoting angiogenesis.

    abstract::Among the key effects of fluid shear stress on vascular endothelial cells is modulation of gene expression. Promoter sequences termed shear stress response elements (SSREs) mediate the responsiveness of endothelial genes to shear stress. While previous studies showed that shear stress responsiveness is mediated by a s...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1007/s10456-009-9143-7

    authors: Silberman M,Barac YD,Yahav H,Wolfovitz E,Einav S,Resnick N,Binah O

    更新日期:2009-01-01 00:00:00

  • Antiangiogenic therapy promoted metastasis of hepatocellular carcinoma by suppressing host-derived interleukin-12b in mouse models.

    abstract::Antiangiogenic therapy, specially sorafenib, has become the standard of care for patients with advanced hepatocellular carcinoma (HCC), however, the improvement in survival time is not satisfactory. Previous studies have found that, in some circumstances, antiangiogenic therapy promoted tumor metastasis and the mechan...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1007/s10456-013-9357-6

    authors: Zhu XD,Sun HC,Xu HX,Kong LQ,Chai ZT,Lu L,Zhang JB,Gao DM,Wang WQ,Zhang W,Zhuang PY,Wu WZ,Wang L,Tang ZY

    更新日期:2013-10-01 00:00:00

  • Multiple angiogenesis stimulators in a single malignancy: implications for anti-angiogenic tumour therapy.

    abstract::Anti-angiogenesis is likely to develop into a novel therapeutic approach for patients with solid malignancies. Most current clinical trials evaluate anti-angiogenic drugs aimed primarily against single angiogenesis stimulators. Here, we show that a single solid malignancy, i.e., a human embryonal rhabdomyosarcoma, pro...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1023/a:1016045012466

    authors: Pavlakovic H,Havers W,Schweigerer L

    更新日期:2001-01-01 00:00:00

  • Influence of the oxygen microenvironment on the proangiogenic potential of human endothelial colony forming cells.

    abstract::Therapeutic angiogenesis is a promising strategy to promote the formation of new or collateral vessels for tissue regeneration and repair. Since changes in tissue oxygen concentrations are known to stimulate numerous cell functions, these studies have focused on the oxygen microenvironment and its role on the angiogen...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1007/s10456-009-9152-6

    authors: Decaris ML,Lee CI,Yoder MC,Tarantal AF,Leach JK

    更新日期:2009-01-01 00:00:00

  • Ocular drug development--future directions.

    abstract::Technology has caught up with retinal diseases of neovasculature. Work with anti-cancer, anti-angiogenic agents has fueled the way for ocular therapeutics. The market size for age-related macular degeneration and diabetic retinopathy is huge. Fifteen million people in the United States alone have age-related macular d...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1007/s10456-007-9068-y

    authors: Sherris D

    更新日期:2007-01-01 00:00:00

  • The clinical application of angiostatic therapy in combination with radiotherapy: past, present, future.

    abstract::Although monotherapy with angiostatic drugs is still far from effective, there is abundant evidence that angiostatic therapy can improve the efficacy of conventional treatments like radiotherapy. This has instigated numerous efforts to optimize and clinically implement the combination of angiostatic drugs with radiati...

    journal_title:Angiogenesis

    pub_type: 历史文章,杂志文章,评审

    doi:10.1007/s10456-017-9546-9

    authors: Hamming LC,Slotman BJ,Verheul HMW,Thijssen VL

    更新日期:2017-05-01 00:00:00